~~<i id='B77CFA3961'><strike id='B77CFA3961'><tt id='B77CFA3961'><pre id='B77CFA3961'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

explore

focus

author：focus 2025-10-02 14:22:48 - browse：14433

the shape of a medical note connected by dots and lines — health tech coverage from STAT — Adobe

In recent months, the federal government has repeatedly told Medicare Advantage insurers that they cannot use artificial intelligence or algorithms to deny medical services the government routinely covers.

But in finalizing a rule to that effect, it also stepped into a thicket of questions from insurers about a technology that is especially difficult to pin down: What is AI? Can it be used at all to make decisions about the coverage of older patients? If so, how?

This week, the federal agency that oversees Medicare sought to boil it all down into a simple directive: Put the circumstances of the individual patient first, and your algorithm second.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： Kellogg’s is going to war over Mexico’s nutrition label rules

focus

explore

hotspot

entertainment

Wikipedia

hotspot

JohnMoore/GettyImages“Howhastheclinicalworkyoudoaffectedyoupersonally?”We’dcometotheQ&Apartofthe

WSS

Listen: Vivek Ramaswamy's star turn & leaky drug data

Study: Spinal cord stimulation helps patients with paralysis walk again

PBMs are inflating the cost of generic drugs. They must be reined in

Listen: Vivek Ramaswamy's star turn & leaky drug data

Meadows told special counsel he could not recall Trump ever declassifying Mar

Medicare Advantage overpayments discussion gets experts fired up

explore

focus

focus

Medicare details structure of new drug price negotiation program

FDA greenlights medical device to combat bladder issues

Hepatitis C has a cure — but many Americans still lack access to it

Physician assistants need a new name. Here's what it should be

Hepatitis C has a cure — but many Americans still lack access to it

JPM 2024 Review: Hope for the XBI, deals from J&J, Merck, GSK

As demand for Covid shots wanes, Moderna seeks its next success

Rune Labs, whose app tracks Parkinson's symptoms, raises $12M

Medical leaders decry Supreme Court decision on affirmative action

FDA advisory panel to debate high blood pressure devices

explore

How the first Native Hawaiian psychiatrist helped diversify medicine

A preacher's new calling: Diversifying neuroscience research

Allen Institute goes after foundational questions, CEO Costa says

At JPM 2024, hospital systems pitch financial strength to investors

Trans patients at the end of life deserve respect and dignity

Hospital chaplains balance Covid safety with patients’ spiritual needs

hotspot

entertainment

Wikipedia

hotspot